HIV patients with insulin-resistant lipodystrophia have altered hepatic expression of SREBP1 and peroxisome proliferator-activated receptor gamma (PPARγ), compared with NAFLD or control subjects, which contributes to pathogenesis of steatosis and fibrosis [28]. The gene discussed is SREBF1; the disease is metabolic dysfunction-associated steatotic liver disease.